Assessment of Murine Retinal Acuity Ex Vivo Using Multielectrode Array Recordings.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
03 01 2023
Historique:
entrez: 4 1 2023
pubmed: 5 1 2023
medline: 7 1 2023
Statut: ppublish

Résumé

Visual acuity, measured by resolution of optotypes on a standard eye chart, is a critical clinical test for function of the visual system in humans. Behavioral tests in animals can be used to estimate visual acuity. However, such tests may be limited in the study of mutants or after synthetic vision restoration techniques. Because the total response of the retina to a visual scene is encoded in spiking patterns of retinal ganglion cells, it should be possible to estimate visual acuity in vitro from the retina by analyzing retinal ganglion cell output in response to test stimuli. We created a method, EyeCandy, that combines a visual stimulus-generating engine with analysis of multielectrode array retinal recordings via a machine learning approach to measure murine retinal acuity in vitro. Visual stimuli included static checkerboards, drifting gratings, and letter optotypes. In retinas from wild-type C57Bl/6 mice, retinal acuity measurement for a drifting grating was 0.4 cycles per degree. In contrast, retinas from adult rd1 mice with outer retinal degeneration showed no detectable acuity. A comparison of acuities among different regions of the retina revealed substantial variation, with the inferior-nasal quadrant having highest RA. Letter classification accuracy of a projected Early Treatment Diabetic Retinopathy eye chart reached 99% accuracy for logMAR 3.0 letters. EyeCandy measured a restored RA of 0.05 and 0.08 cycles per degree for static and dynamic stimuli respectively from the retina of the rd1 mouse treated with the azobenzene photoswitch BENAQ. Machine learning may be used to estimate retinal acuity. The use of ex vivo retinal acuity measurement may allow determination of effects of mutations, drugs, injury, or other manipulations on retinal visual function.

Identifiants

pubmed: 36598460
pii: 2785259
doi: 10.1167/tvst.12.1.4
pmc: PMC9832724
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Subventions

Organisme : NEI NIH HHS
ID : P30 EY001730
Pays : United States
Organisme : NEI NIH HHS
ID : R24 EY023937
Pays : United States

Références

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):E2391-8
pubmed: 22891316
Vision Res. 2000;40(16):2201-9
pubmed: 10878281
Mol Vis. 2008;14:2518-27
pubmed: 19112529
Sci Rep. 2019 Sep 19;9(1):13561
pubmed: 31537864
Front Cell Neurosci. 2015 Aug 25;9:330
pubmed: 26379501
J Neurosci. 2017 Jan 18;37(3):610-625
pubmed: 28100743
Sci Rep. 2017 Apr 13;7:45487
pubmed: 28406473
Cells. 2019 Jun 26;8(7):
pubmed: 31247948
J Neurophysiol. 1997 Nov;78(5):2336-50
pubmed: 9356386
Neuron. 2017 Feb 22;93(4):767-776.e6
pubmed: 28231464
J Gen Physiol. 1958 Mar 20;41(4):675-92
pubmed: 13514004
Genes Brain Behav. 2006 Jul;5(5):389-403
pubmed: 16879633
Sci Rep. 2016 Sep 21;6:33565
pubmed: 27650332
J Biomech Eng. 2017 Dec 1;139(12):
pubmed: 28975276
J Neurophysiol. 2008 Mar;99(3):1408-21
pubmed: 18216234
Artif Intell Med. 2019 May;96:134-141
pubmed: 31164207
J Physiol. 1984 Dec;357:575-607
pubmed: 6512705
J Biomed Opt. 2015;20(12):126005
pubmed: 26677070
Nat Rev Neurosci. 2009 Mar;10(3):173-85
pubmed: 19229240
Br J Ophthalmol. 2014 Jul;98(7):852-6
pubmed: 24403565
Neuron. 2012 Oct 18;76(2):266-80
pubmed: 23083731
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3827-3836
pubmed: 30737290
PLoS Biol. 2009 Mar;7(3):e1000074
pubmed: 19855814
Annu Rev Neurosci. 2013 Jul 8;36:467-88
pubmed: 23724995
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5936-41
pubmed: 19297621
Arch Ophthalmol. 1992 Nov;110(11):1634-9
pubmed: 1444925
J Gen Physiol. 1957 Jul 20;40(6):925-48
pubmed: 13439169
J Clin Invest. 2017 Jun 30;127(7):2598-2611
pubmed: 28581442
Nat Commun. 2022 Jan 26;13(1):513
pubmed: 35082313
Nat Med. 2021 Jul;27(7):1223-1229
pubmed: 34031601
Front Cell Neurosci. 2015 Jul 29;9:277
pubmed: 26283914
PLoS One. 2014 Jul 16;9(7):e102392
pubmed: 25029531
J Neurosci. 2008 Jan 2;28(1):189-98
pubmed: 18171936
Neuron. 2019 May 8;102(3):574-586.e5
pubmed: 30876849
Cereb Cortex. 2018 Dec 1;28(12):4136-4160
pubmed: 29059288
J Neurosci. 2013 Sep 18;33(38):14989-97
pubmed: 24048828
Science. 2010 Jul 23;329(5990):413-7
pubmed: 20576849
Mamm Genome. 2000 Jul;11(7):531-6
pubmed: 10886018
Invest Ophthalmol Vis Sci. 1981 Mar;20(3):285-93
pubmed: 6162818
Front Cell Neurosci. 2018 Dec 07;12:481
pubmed: 30581379
Nat Med. 2022 Jun;28(6):1149-1156
pubmed: 35715505
Am J Ophthalmol. 1982 Jul;94(1):91-6
pubmed: 7091289
Neuron. 2006 Apr 6;50(1):23-33
pubmed: 16600853

Auteurs

Darwin Babino (D)

Departments of Ophthalmology, University of Washington School of Medicine, Seattle, WA, USA.

Tyler Benster (T)

Departments of Ophthalmology, University of Washington School of Medicine, Seattle, WA, USA.
Neurosciences Program, Stanford University School of Medicine, Stanford, CA, USA.

Laura Laprell (L)

Departments of Ophthalmology, University of Washington School of Medicine, Seattle, WA, USA.

Russell N Van Gelder (RN)

Departments of Ophthalmology, University of Washington School of Medicine, Seattle, WA, USA.
Biological Structure, University of Washington School of Medicine, Seattle, WA, USA.
Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.
Roger and Angie Karalis Johnson Retina Center, University of Washington School of Medicine, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH